Matthew Rettig

14PUBLICATIONS
211CO-AUTHORS
Primary health carePredictive and prognostic markersMolecular targetsPharmaceutical delivery technologiesRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 30, 2026
A Comparison of Prostate Cancer Incidence and Mortality Rates in the Veterans Affairs Healthcare system and the Surveillance, Epidemiology, and End Results Program.

|Jun 05, 2026
Deep learning models built from PSMA PET of the primary tumor can predict synchronous and metachronous prostate cancer metastases.

|Aug 08, 2024
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway).

Maha Hussain, Masha Kocherginsky, Neeraj Agarwal

|Jul 16, 2024
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study.

John Nikitas, Kritika Subramanian, Nimrod Barashi Gozal

|Feb 01, 2024
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer.

Tanya Dorff, Lisa G Horvath, Karen Autio

|Jan 16, 2024
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide.

Wassim Abida, Andrew W Hahn, Neal Shore

Pageof 3

Frequent Collaborators

4 joint publications

Tomasz M Beer

4 joint publications

Joshi J Alumkal

3 joint publications

Raunak Shrestha

3 joint publications

Jonathan Chou